Advancing Cell Therapy Manufacturing Through Automation-Ready Tools & Flexible GMP Reagents for Scalable Production

• Implementing automation-capable manufacturing solutions to reduce operator variability and lower cost of goods while maintaining GMP compliance throughout production
• Deploying flexible GMP reagents for T cell workflows to accommodate emerging requirements and enable process optimization across therapeutic modalities
• Leveraging single-use bioreactor systems designed for cell therapy to standardize culture conditions and facilitate clinical-to-commercial technology transfer

Speakers:

Evan Zynda

Senior Staff Scientist

Thermo Fisher Scientific Inc